Zou, Ping
Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. [electronic resource]
- Journal of virology Sep 2007
- 10029-36 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
ISSN: 0022-538X
Standard No.: 10.1128/JVI.02241-06 doi
Subjects--Topical Terms: Animals Antineoplastic Agents--pharmacology Apoptosis--drug effects Baculoviral IAP Repeat-Containing 3 Protein Boronic Acids--pharmacology Bortezomib Burkitt Lymphoma--drug therapy Caspase 8--metabolism Caspase 9--metabolism Cell Line, Tumor Cell Transformation, Viral--drug effects Herpesvirus 4, Human--metabolism Humans Inhibitor of Apoptosis Proteins--metabolism Mice Mice, SCID Multiple Myeloma--drug therapy NF-kappa B p50 Subunit--metabolism Proteasome Endopeptidase Complex--metabolism Proteasome Inhibitors Proto-Oncogene Proteins c-bcl-2--metabolism Pyrazines--pharmacology Signal Transduction--drug effects Transcription Factor RelA--metabolism Ubiquitin-Protein Ligases Viral Matrix Proteins--metabolism Virus Latency--drug effects X-Linked Inhibitor of Apoptosis Protein--metabolism Xenograft Model Antitumor Assays bcl-X Protein--metabolism